Phase I study of subcutaneously administered interleukin-2 in combination with interferon alfa-2a in patients with advanced cancer

  • B. L. Gause
  • , M. Sznol
  • , W. C. Kopp
  • , John Edward Janik
  • , II W. Smith
  • , R. G. Steis
  • , W. J. Urba
  • , W. Sharfman
  • , R. G. Fenton
  • , S. P. Creekmore
  • , J. Holmlund
  • , K. C. Conlon
  • , L. A. VanderMolen
  • , D. L. Longo

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I study of subcutaneously administered interleukin-2 in combination with interferon alfa-2a in patients with advanced cancer'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science